Postmenopausal syndrome

Indian Journal of Psychiatry

Volumn 57, Issue , 2015, Pages 222-232

  Dalal, Pronob K ^a   Agarwal, Manu ^a  

^a UNIVERSITY OF LUCKNOW   (India)

Author keywords

Hot flushes; menopausal depression; postmenopausal syndrome

Indexed keywords

ALPHA TOCOPHEROL; CITALOPRAM; CLONIDINE; CONJUGATED ESTROGEN; ESTROGEN; FLUOXETINE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PROGESTERONE; VENLAFAXINE; ALENDRONIC ACID; CALCIUM; CORTICOSTEROID; ESTRADIOL; VITAMIN D;

BIPOLAR DISORDER; COGNITION; DEPRESSION; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FAMILY HISTORY; FATIGUE; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INTERPERSONAL STRESS; LIFE STRESS; MENOPAUSAL SYNDROME; MENTAL INSTABILITY; OBSESSIVE COMPULSIVE DISORDER; OSTEOPOROSIS; PANIC; PSYCHOLOGICAL ASPECT; REVIEW; SCHIZOPHRENIA; SLEEP DISORDER; SOCIAL STATUS; SOCIAL SUPPORT; SYSTEMIC THERAPY; UNEMPLOYMENT; UROGENITAL TRACT ATROPHY; UROGENITAL TRACT DISEASE; VASOMOTOR DISORDER; ANDROGEN THERAPY; COUNSELING; MAJOR DEPRESSION; MOOD DISORDER; OBESITY; OSTEOLYSIS; PATHOPHYSIOLOGY; PREMENSTRUAL DYSPHORIC DISORDER; PUERPERAL DEPRESSION; SLEEP DISORDERED BREATHING; SYMPTOM; URINARY TRACT INFECTION; URINE INCONTINENCE; UROGENITAL ATROPHY;

EID: 84938396370     PISSN: 00195545     EISSN: 19983794     Source Type: Journal    
DOI: 10.4103/0019-5545.161483     Document Type: Review

References (107)

1. Sherwin B. Menopause: Myths and realities. Psychological aspects of women's health care. In: Stotland NL, Stewart DE, editors. The Interface Between Psychiatry and Obstetrics and Gynecology. Arlington: American Psychiatric Publishing; 2001. p. 241-59.
2. Spinelli MG. Depression and hormone therapy. Clin Obstet Gynecol 2004;47:428-36.
3. Adena MA, Gallagher HG. Cigarette smoking and the age at menopause. Ann Hum Biol 1982;9:121-30.
4. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: Identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987;47:94-100.
5. Soares CN, Taylor V. Effects and management of the menopausal transition in women with depression and bipolar disorder. J Clin Psychiatry 2007;68 Suppl 9:16-21.
6. Baram D. Physiology and symptoms of menopause. In: Steward DE, Robinson GE, editors. A Clinician's Guide to Menopause. Washington, DC: Health Press International; 1997. p. 9-28.
7. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874-8.
8. Schiff I, Regestein Q, Tulchinsky D, Ryan KJ. Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA 1979;242:2405-4.
9. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065-79.
10. Genant HK, Lucas J, Weiss S, Akin M, Emkey R, McNaney?Flint H, et al. Low?dose esterified estrogen therapy: Effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group. Arch Intern Med 1997;157:2609-15.
11. Weiss SR, Ellman H, Dolker M. A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transdermal Estradiol Investigator Group. Obstet Gynecol 1999;94:330-6.
12. Schiff I, Tulchinsky D, Cramer D, Ryan KJ. Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA 1980;244:1443-5.
13. Freedman RR, Woodward S, Sabharwal SC. Alpha 2?adrenergic mechanism in menopausal hot flushes. Obstet Gynecol 1990;76:573-8.
14. Nagamani M, Kelver ME, Smith ER. Treatment of menopausal hot flashes with transdermal administration of clonidine. Am J Obstet Gynecol 1987;156:561-5.
15. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial. JAMA 2003;289:2827-34.
16. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002;20:1578-83.
17. Suvanto?Luukkonen E, Koivunen R, Sundström H, Bloigu R, Karjalainen E, Haiva?Mallinen L, et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: A prospective, randomized, 9?month, placebo?controlled, double?blind study. Menopause 2005;12:18-26.
18. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial. Lancet 2000;356:2059-63.
19. Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998;16:495-500.
20. Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, et al. Relation of demographic and lifestyle factors to symptoms in a multi?racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-73.
21. Whiteman MK, Staropoli CA, Langenberg PW, McCarter RJ, Kjerulff KH, Flaws JA. Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol 2003;101:264-72.
22. Handa VL, Bachus KE, Johnston WW, Robboy SJ, Hammond CB. Vaginal administration of low?dose conjugated estrogens: Systemic absorption and effects on the endometrium. Obstet Gynecol 1994;84:215-8.
23. Eriksen B. A randomized, open, parallel?group study on the preventive effect of an estradiol?releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999;180:1072-9.
24. Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T, et al. Postmenopausal hormones and incontinence: The Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 2001;97:116-20.
25. Cauley JA, Zmuda JM, Ensrud KE, Bauer DC, Ettinger B, Study of Osteoporotic Fractures Research Group. Timing of estrogen replacement therapy for optimal osteoporosis prevention. J Clin Endocrinol Metab 2001;86:5700-5.
26. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
27. Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M. Ultralow?dose micronized 17beta?estradiol and bone density and bone metabolism in older women: A randomized controlled trial. JAMA 2003;290:1042-8.
28. Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA 2002;287:2668-76.
29. Ettinger B, Ensrud KE, Wallace R, Johnson KC, Cummings SR, Yankov V, et al. Effects of ultralow?dose transdermal estradiol on bone mineral density: A randomized clinical trial. Obstet Gynecol 2004;104:443-51.
30. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett?Connor E, Musliner TA, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial. JAMA 1998;280:2077-82.
31. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA 1999;282:1344-52.
32. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3?year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999;282:637-45.
33. Soares CN. Perimenopause?related Mood Disturbance: An Update on Risk Factors and Novel Treatment Strategies Available. In: Meeting Program and Abstracts. Psychopharmacology and Reproductive Transitions Symposium. American Psychiatric Association 157th Annual Meeting; May 1-6, 2004; New York, Arlington, VA: American Psychiatric Publishing; 2004. p. 51-61.
34. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62-70.
35. Maartens LW, Knottnerus JA, Pop VJ. Menopausal transition and increased depressive symptomatology: A community based prospective study. Maturitas 2002;42:195-200.
36. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: The Harvard study of moods and cycles. Arch Gen Psychiatry 2006;63:385-90.
37. Steiner M, Dunn E, Born L. Hormones and mood: From menarche to menopause and beyond. J Affect Disord 2003;74:67-83.
38. Halbreich U. Role of estrogen in postmenopausal depression. Neurology 1997;48:S16-9.
39. Huttner RP, Shepherd JE. Gonadal steroids, selective serotonin reuptake inhibitors, and mood disorders in women. Med Clin North Am 2003;87:1065-76.
40. Sloan DM, Kornstein SG. Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am 2003;26:581-94.
41. Charney DA, Stewart DE. Psychiatric aspects. In: Steward DE, Robinson GE, editors. A Clinician's Guide to Menopause. Washington, DC: Health Press International; 1997. p. 129-44.
42. Payne JL. The role of estrogen in mood disorders in women. Int Rev Psychiatry 2003;15:280-90.
43. Bromberger JT, Assmann SF, Avis NE, Schocken M, Kravitz HM, Cordal A. Persistent mood symptoms in a multiethnic community cohort of pre? and perimenopausal women. Am J Epidemiol 2003;158:347-56.
44. Dennerstein L, Lehert P, Burger H, Dudley E. Mood and the menopausal transition. J Nerv Ment Dis 1999;187:685-91.
45. Rasgon NL, Dunkin J, Fairbanks L, Altshuler LL, Troung C, Elman S, et al. Estrogen and response to sertraline in postmenopausal women with major depressive disorder: A pilot study. J Psychiatr Res 2007;41:338-43.
46. Genazzani AR, Gambacciani M, Simoncini T, Schneider HP. Hormone replacement therapy in climacteric and aging brain. International Menopause Society Expert Workshop, 15-18 March 2003, Pisa, Italy. Climacteric 2003;6:188-203.
47. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979;36:550-4.
48. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347:930-3.
49. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. Estrogen replacement in perimenopause?related depression: A preliminary report. Am J Obstet Gynecol 2000;183:414-20.
50. Schneider MA, Brotherton PL, Hailes J. The effect of exogenous oestrogens on depression in menopausal women. Med J Aust 1977;2:162-3.
51. Schneider HP. Cross?national study of women's use of hormone replacement therapy (HRT) in Europe. Int J Fertil Womens Med 1997;42 Suppl 2:365-75.
52. Zweifel JE, O'Brien WH. A meta?analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189-212.
53. Amsterdam J, Garcia?Espana F, Fawcett J, Quitkin F, Reimherr F, Rosenbaum J, et al. Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord 1999;55:11-7.
54. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA, Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Quality?of?life and depressive symptoms in postmenopausal women after receiving hormone therapy: Results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA 2002;287:591-7.
55. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double?blind, randomized, placebo?controlled trial. Arch Gen Psychiatry 2001;58:529-34.
56. Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, et al. Effects of low?dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas 2005;50:91-7.
57. Schiff R, Bulpitt CJ, Wesnes KA, Rajkumar C. Short?term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross?over study. Psychoneuroendocrinology 2005;30:309-15.
58. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, et al. Effects of estrogen plus progestin on health?related quality of life. N Engl J Med 2003;348:1839-54.
59. Heinrich AB, Wolf OT. Investigating the effects of estradiol or estradiol/ progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: A questionnaire study. Neuropsychobiology 2005;52:17-23.
60. Robinson GE, Stirtzinger R. Psychoeducational programs and support groups at transition to menopause. In: Steward DE, Robinson GE, editors. A Clinician's Guide to Menopause. Washington, DC: Health Press International; 1997. p. 165-80.
61. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population?based study of menopausal symptoms. Obstet Gynecol 2000;96:351-8.
62. La Rue A. Aging and Neuropsychological Assessment. New York: Plenum Press; 1992.
63. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-57.
64. Duka T, Tasker R, McGowan JF. The effects of 3?week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology (Berl) 2000;149:129-39.
65. Caldwell BM, Watson RI. An evaluation of psychologic effects of sex hormone administration in aged women. I. Results of therapy after six months. J Gerontol 1952;7:228-44.
66. Hackman BW, Galbraith D. Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory. Curr Med Res Opin 1976;4:303-6.
67. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA 1998;279:688-95.
68. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 2000;283:1007-15.
69. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 2003;289:2651-62.
70. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2959-68.
71. Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 2002;11:367-77.
72. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, et al. Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002;77:660-5.
73. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: A double?blind, cross?over study. Psychoneuroendocrinology 1985;10:325-35.
74. Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 2003;79:1341-52.
75. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-8.
76. Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, et al. Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol 2005;105:944-52.
77. Soares CN, Joffe H, Steiner M. Menopause and mood. Clin Obstet Gynecol 2004;47:576-91.
78. Murphy PJ, Campbell SS. Sex hormones, sleep, and core body temperature in older postmenopausal women. Sleep 2007;30:1788-94.
79. Krystal AD. Depression and insomnia in women. Clin Cornerstone 2004;6 Suppl 1B: S19-28.
80. Miller EH. Women and insomnia. Clin Cornerstone 2004;6 Suppl 1B: S8-18.
81. Shin K, Shapiro C. Menopause, sex hormones, and sleep. Bipolar Disord 2003;5:106-9.
82. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003;28 Suppl 2:17-54.
83. Marsh WK, Templeton A, Ketter TA, Rasgon NL. Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: Preliminary report. J Psychiatr Res 2008;42:247-51.
84. Burt VK, Rasgon N. Special considerations in treating bipolar disorder in women. Bipolar Disord 2004;6:2-13.
85. Claudia P, Andrea C, Chiara C, Stefano L, Giuseppe M, Vincenzo DL, et al. Panic disorder in menopause: A case control study. Maturitas 2004;48:147-54.
86. Smoller JW, Pollack MH, Wassertheil?Smoller S, Barton B, Hendrix SL, Jackson RD, et al. Prevalence and correlates of panic attacks in postmenopausal women: Results from an ancillary study to the Women's Health Initiative. Arch Intern Med 2003;163:2041-50.
87. Lochner C, Hemmings SM, Kinnear CJ, Moolman?Smook JC, Corfield VA, Knowles JA. Corrigendum to gender in obsessive?compulsive disorder: Clinical and genetic findings. Eur Neuropsychopharmacol 2004;14:437-45.
88. Bluming AZ. Hormone replacement therapy: Benefits and risks for the general postmenopausal female population and for women with a history of previously treated breast cancer. Semin Oncol 1993;20:662-74.
89. Burkman RT, Collins JA, Greene RA. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol 2001;185:S13-23.
90. Gorsky RD, Koplan JP, Peterson HB, Thacker SB. Relative risks and benefits of long?term estrogen replacement therapy: A decision analysis. Obstet Gynecol 1994;83:161-6.
91. Col NF, Eckman MH, Karas RH, Pauker SG, Goldberg RJ, Ross EM, et al. Patient?specific decisions about hormone replacement therapy in postmenopausal women. JAMA 1997;277:1140-7.
92. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001;344:276-85.
93. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997;350:1047-59.
94. Ross RK, Paganini?Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000;92:328-32.
95. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: A meta?analysis. Obstet Gynecol 1995;85:304-13.
96. Syamala TS, Sivakami M. India Women Reaching Menopause at 30: Study, in Times of India. Benett Coleman and Co.: New Delhi; 2007.
97. Brambilla DJ, McKinlay SM, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol 1994;140:1091-5.
98. Chowta NK, Sebastian J, Chowta MN. Comparative study of menopausal symptoms in post menopausal and perimenopausal women. J Clin Diagn Res 2008;2:959-62.
99. Taylor DL, Fonseka P. Symptom experience of Filipino American midlife women. Menopause 1999;6:105-14.
100. Goonaratna C, Fonseka P, Wijeywardene K. Perimenopausal symptoms in Sri Lankan women. Ceylon Med J 1999;44:63-9.
101. Lagos X, Navarro N, Illanes E, Bustos L. Prevalence of biological and psychological symptoms in perimenopausal women from different socioeconomic levels in the city of Temuco. Rev Med Chil 1998;126:1189-94.
102. Schindler BA. The psychiatric disorders of midlife. Med Clin North Am 1987;71:71-85.
103. Singh M, Singh G. A comparison of mental health status during menopause and post?menopause middle?aged working women. Internet J World Health Soc Politics 2007;4:61-9.
104. Sagsöz N, Oguztürk O, Bayram M, Kamaci M. Anxiety and depression before and after the menopause. Arch Gynecol Obstet 2001;264:199-202.
105. Prakash IJ, Murthy VN. Psychiatric morbidity and the menopause. Indian J Psychiatry 1981;23:242-6.
106. Indira SN, Murthy VN. Nature of psychiatric disturbances in menopausal women. Indian J Clin Psychol 1980;7:7.
107. Nagar S, Dave P. Perception of women towards physiological problems faced at menopause. Anthropologist 2005;7:173-5.